Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hospital Infection Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hospital Infection Therapeuticsmarket, defines the market attractiveness level of Hospital Infection Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hospital Infection Therapeutics industry, describes the types of Hospital Infection Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hospital Infection Therapeutics market and the development prospects and opportunities of Hospital Infection Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hospital Infection Therapeutics market in Chapter 13.
By Player:
Sanofi
Bristol Myers Squibb Company
Johnson & Johnson Services
GlaxoSmithkline
Actavis
Bayer
Pfizer
Cubist Pharmaceuticals
Merck
AstraZeneca
By Type:
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
By End-User:
Hospital Acquired Pneumonia
Surgical Site Infections
Urinary Tract Infection
Gastrointestinal Disorders
Bloodstream Infections
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hospital Infection Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hospital Infection Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hospital Infection Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hospital Infection Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hospital Infection Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Hospital Infection Therapeutics Consumption (2017-2022)
-
7.2 United States Hospital Infection Therapeutics Consumption (2017-2022)
-
7.3 Europe Hospital Infection Therapeutics Consumption (2017-2022)
-
7.4 China Hospital Infection Therapeutics Consumption (2017-2022)
-
7.5 Japan Hospital Infection Therapeutics Consumption (2017-2022)
-
7.6 India Hospital Infection Therapeutics Consumption (2017-2022)
-
7.7 South Korea Hospital Infection Therapeutics Consumption (2017-2022)
8 Region and Country-wise Hospital Infection Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Hospital Infection Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Hospital Infection Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Hospital Infection Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Hospital Infection Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Hospital Infection Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Hospital Infection Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Hospital Infection Therapeutics Consumption Forecast (2022-2028)
9 Global Hospital Infection Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Hospital Infection Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antibacterial Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antiviral Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Antifungal Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Hospital Infection Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Acquired Pneumonia Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Surgical Site Infections Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Urinary Tract Infection Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Gastrointestinal Disorders Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Bloodstream Infections Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Global Hospital Infection Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Hospital Infection Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antibacterial Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Antiviral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Antifungal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hospital Infection Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Acquired Pneumonia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Surgical Site Infections Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Urinary Tract Infection Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Gastrointestinal Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Bloodstream Infections Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Hospital Infection Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hospital Infection Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hospital Infection Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hospital Infection Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hospital Infection Therapeutics Market Competitive Analysis
-
14.1 Sanofi
-
14.1.1 Sanofi Company Details
-
14.1.2 Sanofi Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi Hospital Infection Therapeutics Product and Service
-
14.2 Bristol Myers Squibb Company
-
14.2.1 Bristol Myers Squibb Company Company Details
-
14.2.2 Bristol Myers Squibb Company Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol Myers Squibb Company Hospital Infection Therapeutics Product and Service
-
14.3 Johnson & Johnson Services
-
14.3.1 Johnson & Johnson Services Company Details
-
14.3.2 Johnson & Johnson Services Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Johnson & Johnson Services Hospital Infection Therapeutics Product and Service
-
14.4 GlaxoSmithkline
-
14.4.1 GlaxoSmithkline Company Details
-
14.4.2 GlaxoSmithkline Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithkline Hospital Infection Therapeutics Product and Service
-
14.5 Actavis
-
14.5.1 Actavis Company Details
-
14.5.2 Actavis Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Actavis Hospital Infection Therapeutics Product and Service
-
14.6 Bayer
-
14.6.1 Bayer Company Details
-
14.6.2 Bayer Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bayer Hospital Infection Therapeutics Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Hospital Infection Therapeutics Product and Service
-
14.8 Cubist Pharmaceuticals
-
14.8.1 Cubist Pharmaceuticals Company Details
-
14.8.2 Cubist Pharmaceuticals Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Cubist Pharmaceuticals Hospital Infection Therapeutics Product and Service
-
14.9 Merck
-
14.9.1 Merck Company Details
-
14.9.2 Merck Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Merck Hospital Infection Therapeutics Product and Service
-
14.10 AstraZeneca
-
14.10.1 AstraZeneca Company Details
-
14.10.2 AstraZeneca Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 AstraZeneca Hospital Infection Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hospital Infection Therapeutics
-
Figure Hospital Infection Therapeutics Picture
-
Table Global Hospital Infection Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hospital Infection Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hospital Infection Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hospital Infection Therapeutics Consumption by Country (2017-2022)
-
Figure United States Hospital Infection Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Hospital Infection Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Hospital Infection Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Hospital Infection Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Hospital Infection Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hospital Infection Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Infection Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Hospital Infection Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hospital Infection Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hospital Infection Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hospital Infection Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hospital Infection Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hospital Infection Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibacterial Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Antiviral Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Antifungal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Acquired Pneumonia Consumption and Growth Rate (2017-2022)
-
Figure Global Surgical Site Infections Consumption and Growth Rate (2017-2022)
-
Figure Global Urinary Tract Infection Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Bloodstream Infections Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Antibacterial Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antiviral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antifungal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Acquired Pneumonia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgical Site Infections Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Urinary Tract Infection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bloodstream Infections Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hospital Infection Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hospital Infection Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Hospital Infection Therapeutics Product and Service
-
Table Bristol Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol Myers Squibb Company Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol Myers Squibb Company Hospital Infection Therapeutics Product and Service
-
Table Johnson & Johnson Services (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Services Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Services Hospital Infection Therapeutics Product and Service
-
Table GlaxoSmithkline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithkline Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithkline Hospital Infection Therapeutics Product and Service
-
Table Actavis (Foundation Year, Company Profile and etc.)
-
Table Actavis Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis Hospital Infection Therapeutics Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Hospital Infection Therapeutics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Hospital Infection Therapeutics Product and Service
-
Table Cubist Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Cubist Pharmaceuticals Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cubist Pharmaceuticals Hospital Infection Therapeutics Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Hospital Infection Therapeutics Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Hospital Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Hospital Infection Therapeutics Product and Service
-
